SCHEMBL9367295

SCHEMBL9367295

CC=C(C=CC(=O)O)CC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
TP53 P04637 1/20 0.47
EGLN1 Q9GZT9 1/20 0.47
EGLN3 Q9H6Z9 1/20 0.47
HCAR2 Q8TDS4 7/20 0.44
FFAR3 O14843 1/20 0.38
GABRR1 P24046 2/20 0.35
GABRR2 P28476 2/20 0.35
BLM P54132 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
GABRR3 A8MPY1 1/20 0.35
LMNA P02545 1/20 0.35
APEX1 P27695 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
ALOX15 P16050 1/20 0.34
RECQL P46063 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9367291 1.00 TSHR (0.47) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL11852735 0.82 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL28413175 0.82 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL11852741 0.82 TSHR (0.45) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL7154074 0.80 HCAR2 (0.43) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL8920771 0.80 TSHR (0.43) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL7154072 0.80 HCAR2 (0.43) TSHRTP53EGLN1EGLN3HCAR2
SCHEMBL8920758 0.80 TSHR (0.43) TSHRTP53EGLN1EGLN3HCAR2
Bicarbonate SCHEMBL11121484 0.79 FFAR3 (0.38) TSHRHCAR2FFAR3TDP1ALDH1A1
Fumaric Acid SCHEMBL10381001 0.77 FFAR3 (0.67) TSHRTP53EGLN1EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
EP-3027754-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING enEvolv, Inc. (US) 2016-06-08 EP disclosed
WO-2015017866-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. (US) 2015-02-05 WO disclosed
EP-0483674-B1 A process for producing an aliphatic amide and salts thereof FUJISAWA PHARMACEUTICAL CO (JP) 1994-12-28 EP disclosed
US-5254733-A Reacting 2-ethylcrotonaldehyde with willig reagent, then dinitrogen trioxide FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-19 US disclosed
EP-0483674-A1 A process for producing an aliphatic amide and salts thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-06 EP disclosed
US-4863926-A ANTICOAGULANTS, HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
US-4782088-A HYPOTENSIVE, ANTITHROMBOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
US-4778804-A ANTICOAGULANTS, HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-10-18 US disclosed
US-4767768-A ANTITHROMBIC, HYPOTENSIVE; OXIME-SUBSTITUTED FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-08-30 US disclosed
EP-0113106-B1 NEW NITRO ALIPHATIC COMPOUNDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0113106-A1 New nitro aliphatic compounds, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-11 EP disclosed